In a nutshell
We had the following new developments in the past quarter:
- EDBI takes a closer look at China and Southeast Asia’s agri-food ecosystem
- EDBI participated in a fireside chat at the UBS Tech Summit, sharing insights on how we complement the tech ecosystem in Singapore
- Learn more on how we partner our portfolio companies to provide support and collaborative partnerships
- Portfolio developments in Singapore: Hummingbird Bioscience opens a new R&D facility, MiRXES launches two laboratories to identify early cancer biomarkers, and AvePoint establishes a new R&D hub and commits to hiring over 500 local professionals by 2026
- Accomplishments: EDBI and DataStax were featured in a video interview by Singapore Business Review on real-time data applications, Us2.ai participated in Healthcare InnoMatch 2022 and was the only winner awarded with 2 test-beds, M-DAQ expands into Japan and ShopBack enters Hong Kong
- New partnerships with Fazz, ImmunoScape, Pindrop and Moveon
